News & Events

Novartis on Shanghai Stock Exchange?
Reported by ChinaBio Today, Novartis (NYSE: NVS) is contemplating a China IPO (see story). Although such an event would have been inconceivable a few years ago, it may very well happen. By the end of 2012, the Shanghai stock exchange hopes to open an international section for foreign multinationals with an interest in China, which will be initially available for just ten companies. Reportedly, Novartis has been talking to China officials about being a member of the first group.
| ForteBio Sold!
SABPA Seminar: Seizing Opportunities in US and China
First Chinese scientist to win Lasker Award
Pfizer’s XALKORI® (crizotinib) Approved by FDA
上海交大认定人耳鼠技术真实
著名学者饶毅落选中科院院士
Novartis on Shanghai Stock Exchange?
中国最具投资价值城市和园区
王国强:中药的发展要坚持中国标准
CAS Inst of Biophysics and Univ. Penn forms collaborative brain mapping center
US-China Biopharm Congress Philadelphia 2011 / SAPA-GP 9th Annual Conference
Burrill: Huge Payoff of Genomic Project
Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|